Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy. | Ann Pharmacother;28(6): 701-3, 1994 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.

Mooss, A N; Hilleman, D E; Mohiuddin, S M; Hunter, C B.

Affiliation

Mooss AN; Coronary Care Unit, Creighton University Medical Center, Omaha, NE.

Ann Pharmacother ; 28(6): 701-3, 1994 Jun.

Article in En | MEDLINE | ID: mdl-7919552

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Propanolamines / Thrombolytic Therapy / Adrenergic beta-Antagonists / Myocardial Infarction Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1994 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Propanolamines / Thrombolytic Therapy / Adrenergic beta-Antagonists / Myocardial Infarction Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1994 Document type: Article Affiliation country: